FDA Investigator Courtney R Bratina

Courtney R Bratina has conducted inspections on 58 sites in 4 countries as of 10 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
58
Last Inspection Date:
10 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
100000986
Countries of Inspections:
United States of America, Canada, New Zealand, Portugal
FDA Investigators that have inspected at least one site in common with Courtney R Bratina:
Alan E Mehl, Brent W Higgs, Byungja E Marciante, Carl J Montgomery, Carmen Y Fisher, Caroline H Le, Christin L Torres, Christine I Shaw, Daniel Pst Laurent, Diana K Krepel, Elizabeth D Gonzales, Eric M Mueller, PharmD, Erika V Butler, Erin M Mcdowell, Ginger M Sykes, Gloria A Milster, Gwyn G Dickinson, Hanna L Potter, Isabel Y Espinosa, James P Mcreavey, James R Montero, Jamie L Dion, Janet Pulver, Jessica E Hensley, Jonathan R Campos, Joseph R Lambert, Karen M Montgomery (KMM), Kelly D Moore, Kimberley A Hoefen, LCDR Ismael Olvera, IV, Linda F Murphy, Linda K Cline, Linda M Cheny, Linhart, Logan M Jones, Marcus F Yambot, Marion W Nadeau, Matthew M Vernon, Matthew R Dionne, Merril E Racke, Merril Racke, PhD, Michael R Goga, Michael S Kopf, Michele L Obert, Nathan R Moon, Neira Acevedo Ramos, Patricia D Stahnke, Randy V Bong, Richard L Rutherford, Rose Xu, Rowena S Nguyen, Ruth A Williams, Ryan Raffaelli, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sherri N Rohlf, MD, Shirley J Berryman, Stephen T Hansen, Sunitha K Rajaram, PhD, Susan D Yuscius, Tamara L Setzer, Teena H Aiken, Thaddeus M Steinke, Thai T Duong, Theressa B Smith, Vickie J Kanion, Zachary A Bogorad, Zachary L Stamm

Courtney R Bratina's Documents

Publish Date Document Type Title
July, 2021 FDA 483 Nancy A. Krywonis, M.D. - Form 483, 2021-07-23
June, 2023 FDA 483 David J Cahn, M.D. - Form 483, 2023-06-27
November, 2020 FDA 483 Marcello M. Rotta, MD - Form 483, 2020-11-23
January, 2023 FDA 483 Sri Sundaram, M.D. - Form 483, 2023-01-26
December, 2023 FDA 483 Adam J. Wolff, M.D. - Form 483, 2023-12-05
March, 2021 FDA 483 ARISTIDES MANIATIS, M.D. - Form 483, 2021-03-02
May, 2021 EIR Laura Kooienga, M.D. - EIR, 2021-05-21
September, 2020 FDA 483 Michael J. Schurr, MD - Form 483, 2020-09-14
July, 2023 FDA 483 Alan G. Garscadden, M.D. - Form 483, 2023-07-21
February, 2024 FDA 483 TOLMAR, INC - Form 483, 2024-02-23
July, 2021 EIR Nancy A. Krywonis, M.D. - EIR, 2021-07-23
February, 2024 FDA 483 John M Hemmersmeier, M.D. - Form 483, 2024-02-16
October, 2021 FDA 483 Alan G. Garscadden, M.D. - Form 483, 2021-10-22
September, 2021 FDA 483 Val R. Hansen, M.D. - Form 483, 2021-09-03
January, 2022 EIR Andre Kalil, M.D. - EIR, 2022-01-14
January, 2022 FDA 483 Andre Kalil, M.D. - Form 483, 2022-01-14
July, 2020 FDA 483 Karsh, Lawrence, M.D. - Form 483, 2020-07-30
May, 2022 FDA 483 Scott Shannon, M.D. - Form 483, 2022-05-27
August, 2021 FDA 483 Michelle Sato, M.D. - Form 483, 2021-08-13
April, 2023 FDA 483 Sara J Haug, M.D., Ph.D. - Form 483, 2023-04-21
January, 2021 FDA 483 Peter Gottlieb, MD - Form 483, 2021-01-11
March, 2024 FDA 483 Wael Garas, M.D. - Form 483, 2024-03-15
March, 2024 FDA 483 Joe S Mendez, M.D. - Form 483, 2024-03-22
January, 2024 FDA 483 Brian Van Tine - Form 483, 2024-01-26
September, 2024 FDA 483 Kimberly L. Wagner, M.D. - Form 483, 2024-09-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more